Lecanemab, a drug designed to slow the progression of early stage Alzheimer's will not be available to patients in Sweden for ...

The researchers tracked how these people moved between various states: healthy, mild cognitive impairment, and dementia. They also considered the possibility of reversals, where individuals improved ...

Actively Exploring Partnership for Alzheimer’s DevelopmentSupplementary Financing Concluded in Q4 ROCHESTER, N.Y., Nov. 18, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: VCNX), a clinical-stage biotechnology ...

A study of 204 low-income older adults found that 3 out of 4 had undiagnosed cognitive issues — including some who didn’t ...

One of the first studies to investigate the prevalence of unrecognized cognitive impairment among patients seen at Federally ...

Early detection allows for prompt intervention that may slow progression and help manage fears, Dr. Harinderjeet Kaur writes.

Dementia strikes all races, but new research suggests thinking declines in poor seniors are often overlooked.Among a ...

A woman’s “body clock” might affect her dementia risk, according to a new study. The timing of an older woman’s sleep/wake ...

The study of 204 socially and economically vulnerable older adults (average age 70 years) determined that African American individuals had more than twice the odds of unrecognized cognitive impairment ...

For older adults at risk for cognitive decline, especially those with remitted major depressive disorder (rMDD) — with or ...

After re-examining its initial opinion, EMA’s human medicines committee, or CHMP, has recommended granting a marketing authorisation to Leqembi for treating mild cognitive impairment or mild dementia ...